SBIR-STTR Award

Development and Commercialization of Nanostructured Resorbable Urogenital Grafts
Award last edited on: 8/25/15

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$1,710,754
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Chang Yao

Company Information

Nanovis Inc

5865 East State Road 14
Columbia City, IN 46725
   (877) 907-6266
   customer.service@nanovisinc.com
   www.nanovisinc.com
Location: Single
Congr. District: 03
County: Whitley

Phase I

Contract Number: 1R43CA136033-01A2
Start Date: 9/22/10    Completed: 8/31/11
Phase I year
2010
Phase I Amount
$210,755
Bladder cancer is the fourth most common cancer among men and the seventh most common cancer in women with a life expectancy of only five years after diagnosis. Repair of the mid stage of this cancer requires excision of the diseased area. Surprisingly however, regional repair of the genitourinary system and specifically including the repair of the bladder after mid stage (T2) bladder cancer has surprisingly few surgical options despite the recent advances in the development of regenerative scaffolds for other tissues. The most commonly used option for patients requiring resection and replacement of part of their bladder for any reason is the replacement of the resected area with a section of the intestine. The resected tissue can cause serious complications for the patient because it secretes mucus into the bladder, causing stone formation and potentially cancer. Options under development include seeded scaffolds which are likely to offer a solution for replacement of large portions of the bladder but potential procedural complexity and expense may limit their suitability for partial/regional repairs. Acellular matrices offered promise upon introduction to the market but have since been criticized for a lack of long term mechanical strength. For these reasons, the goal of this project is to develop the first synthetic nanostructured regenerative bladder graft material. Nanostructured materials have become a key area of tissue engineering research due to their ability to mimic the roughness and, consequently, the surface energy of natural tissues. Prior work has demonstrated a nanosurface controlled mechanism of moderating protein adsorption driven cell attachment and growth and unexpectedly a bladder repair graft material that reduces bladder stone formation. The proposed product will leverage these findings to create a simple and elegant product solution. The present proposal will reach this goal by focusing on the use of nanostructured multilayered biodegradable polymer matrices. Nanovis will prepare these graft prototypes and evaluate their regenerative properties in vitro and characterize their mechanical and biocompatibility properties. In this manner the specific aims of the proposal will : (i) prepare layered and graded porous nanostructured biodegradable matrices from polyurethane (PU) and poly-lactide-co-glycolide (PLGA) (75:25 wt.% PU:PLGA) scaffolds and characterize its mechanical and chemical properties, (ii) use in vitro models to assess the urothelial and smooth muscle cell functions and the likelihood of calcium stone or bacterial colonization on nanoscale PU and PLGA, and (iii) conduct a preliminary in vivo assessment of the best nanostructured bladder constructs within the budget limitations. , ,

Public Health Relevance:
Surgical repair of the bladder and urogential system is a common procedure yet surprisingly a synthetic regenerative graft material is not available. Nanovis'proposal seeks to develop a synthetic nanostructured bladder graft material that is resistant to bladder stone formation suitable to help the over 50,000 U.S. patients per year in need of such a procedure.

Thesaurus Terms:
Abscission;Achievement;Achievement Attainment;Adsorption;Animals;Area;Autologous;Biliary Or Urinary Stones;Bladder;Bladder Calculi;Bladder Stones;Bladder Tissue;Blood Coagulation Factor Iv;Body Tissues;Budgets;Ca++ Element;Calcium;Calculi;Cancer Staging;Cancer Of Bladder;Cancer Of Urinary Bladder;Cancers;Cell Attachment;Cell Function;Cell Process;Cell Physiology;Cell-Matrix Adhesions;Cell-Matrix Junction;Cells;Cellular Function;Cellular Physiology;Cellular Process;Characteristics;Chemicals;Coagulation Factor Iv;Complex;Cystectomy;Cystoliths;Development;Diagnosis;Diagnostic Neoplasm Staging;Dioxanedione Polymer With Dimethyldioxanedione Polymer;Effectiveness;Excision;Extirpation;Factor Iv;Family Suidae;Funding;Future;Generalized Growth;Genitourinary;Genitourinary System;Glycolic-Lactic Acid Polyester;Goals;Graft Material;Grant;Growth;Histocompatibility;Inflm;In Vitro;Indiana;Infection;Inflammation;Inflammatory;Intestinal;Intestines;Leiomyocyte;Life Expectancy;Malignant Bladder Neoplasm;Malignant Neoplasms;Malignant Tumor;Malignant Tumor Of The Bladder;Malignant Neoplasm Of Urinary Bladder;Marketing;Mechanics;Metabolic;Modeling;Morbidity;Morbidity - Disease Rate;Mucous Body Substance;Mucus;Myocytes, Smooth Muscle;Natural Regeneration;Nature;Neoplasm Staging;Operation;Operative Procedures;Operative Surgical Procedures;Ostamer;Patients;Pellethane;Performance;Phase;Pigs;Poly(Glycolide Lactide)Copolymer;Poly(Lactide-Co-Glycolide);Poly(Lactide-Co-Glycoside);Polyglactin;Polyisocyanates;Polymers;Polyurethanes;Preparation;Procedures;Programs (Pt);Programs [publication Type];Property;Property, Loinc Axis 2;Proteins;Regeneration;Removal;Research;Resected;Resistance;Sight;Smooth Muscle Cells;Smooth Muscle Myocytes;Smooth Muscle Tissue Cell;Solutions;Staging;Stone;Subcellular Process;Suidae;Surface;Surgeon;Surgical;Surgical Interventions;Surgical Procedure;Surgical Removal;Survival Rate;Swine;System;System, Loinc Axis 4;Technology;Temperature;Testing;Tissue Compatibility;Tissue Engineering;Tissue Growth;Tissues;Transplantation;Transplanted Tissue;Tumor Staging;Urinary Bladder Malignant Tumor;Urinary System, Bladder;Urogenital;Urogenital System;Urothelial Cell;Vesical Calculi;Vision;Woman;Work;Base;Biocompatibility;Biodegradable Polymer;Biomaterial Compatibility;Bioresorbable Polymer;Bowel;Cell Type;Chemical Property;Cost;Degradable Polymer;Design;Designing;Engineered Tissue;Gene Product;Implant Material;Implantation;Improved;In Vitro Model;In Vivo;Malignancy;Men;Men's;Mucous;Nano Meter Scale;Nano Meter Sized;Nano Scale;Nano Structured;Nanometer Scale;Nanometer Sized;Nanoscale;Nanostructured;Neoplasm/Cancer;Ontogeny;Porcine;Programs;Prototype;Public Health Relevance;Regenerate;Regenerative;Repair;Repaired;Resection;Resistant;Scaffold;Scaffolding;Success;Suid;Surgery;Transplant;Urinary Bladder;Urogenital System (Urinary Part)

Phase II

Contract Number: 2R44CA136033-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2014
(last award dollars: 2015)
Phase II Amount
$1,499,999

Bladder cancer is the fourth most common cancer among men and the seventh most common cancer in women with a life expectancy of only five years after diagnosis. Repair of advanced bladder cancer requires removal of the bladder and construction of a neo bladder or urinary conduit using autologous bowel. These reconstructions have high chronic complications and cost. Complications stem from donor sight morbidity, mucus secretion and continued absorption of metabolites, drugs and other toxins by the bowel tissue. Metabolic imbalances, calculi formation, and severe diarrhea are common and malignancy and perforation are also reported. Allograft or xenograph materials do not have the absorptive properties of bowel tissue but are believed to have insufficient mechanical properties potentially leading to a life threatening perforation. With the support of a Phase I grant from the NCI, the team previously developed and tested a regenerative bladder graft in adult minipigs achieving bladder tissue regeneration and bladder capacity comparable to use of autologous bowel segments, and achieved supportive in vitro data. To build on these encouraging results the team proposes to apply the previously tested graft nanotechnology to generate a viable and durable urinary conduit in a porcine model that performs as well as a urinary conduit constructed from autologous bowel tissue but that has the potential for reduced complications, surgery time and expense. If this proposed program is successful, the team under Nanovis' infrastructure and financial support plans to commercialize the nanostructured urinary conduit.

Public Health Relevance Statement:


Public Health Relevance:
Surgical repair of the bladder and urogential system is a common procedure yet surprisingly a synthetic regenerative graft material is not available. Nanovis' proposal seeks to develop a synthetic nanostructured urinary conduit that is resistant to bladder stone formation suitable to help the over 50,000 U.S. patients per year in need of such a procedure.

Project Terms:
absorption; Adult; Allografting; Area; Autologous; Bladder; Bladder Calculi; Bladder Tissue; Calculi; Cell physiology; Cell Separation; Characteristics; Chronic; Clinical; commercialization; Complication; cost; Data; design; Development; Diagnosis; Diarrhea; Effectiveness; Event; Excision; Extravasation; Family suidae; Financial Support; Genitourinary system; Glycolic-Lactic Acid Polyester; Grant; Growth; Healthcare Systems; Histocompatibility; Human; Implant; In Vitro; in vitro Model; Intestines; Lead; Life; Life Expectancy; Malignant neoplasm of urinary bladder; Malignant Neoplasms; Mechanics; men; Metabolic; Methods; Miniature Swine; Modeling; Morbidity - disease rate; Mucous body substance; nanoscale; nanostructured; Nanotechnology; Natural regeneration; Operative Surgical Procedures; Organ; Patients; Perforation; Performance; Pharmaceutical Preparations; Phase; Polymers; Polyurethanes; Procedures; programs; Property; public health relevance; reconstruction; regenerative; repaired; Reporting; Research; Research Infrastructure; Resistance; Safety; Savings; Smooth Muscle Myocytes; Staging; stem; Stem cells; success; Surgical sutures; Survival Rate; System; Techniques; Testing; Time; tissue regeneration; Tissues; Toxin; Transplanted tissue; urinary; Urine; urologic; Vision; Woman